Khasawneh, H.; Ferreira Dalla Pria, H.R.; Miranda, J.; Nevin, R.; Chhabra, S.; Hamdan, D.; Chakraborty, J.; Biachi de Castria, T.; Horvat, N.
CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics. J. Clin. Med. 2023, 12, 6821.
https://doi.org/10.3390/jcm12216821
AMA Style
Khasawneh H, Ferreira Dalla Pria HR, Miranda J, Nevin R, Chhabra S, Hamdan D, Chakraborty J, Biachi de Castria T, Horvat N.
CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics. Journal of Clinical Medicine. 2023; 12(21):6821.
https://doi.org/10.3390/jcm12216821
Chicago/Turabian Style
Khasawneh, Hala, Hanna Rafaela Ferreira Dalla Pria, Joao Miranda, Rachel Nevin, Shalini Chhabra, Dina Hamdan, Jayasree Chakraborty, Tiago Biachi de Castria, and Natally Horvat.
2023. "CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics" Journal of Clinical Medicine 12, no. 21: 6821.
https://doi.org/10.3390/jcm12216821
APA Style
Khasawneh, H., Ferreira Dalla Pria, H. R., Miranda, J., Nevin, R., Chhabra, S., Hamdan, D., Chakraborty, J., Biachi de Castria, T., & Horvat, N.
(2023). CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics. Journal of Clinical Medicine, 12(21), 6821.
https://doi.org/10.3390/jcm12216821